The future of new aortic valve replacement approaches

Future Cardiology

Volumn 6, Issue 3, 2010, Pages 351-360

  Bollati, Mario ^a   Tizzani, Emanuele ^a   Moretti, Claudio ^a   Sciuto, Filippo ^a   Omede, Pierluigi ^a   Zoccai, Giuseppe Biondi ^a   Trevi, Gian Paolo ^a   Abbate, Antonio ^b   Sheiban, Imad ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Aortic valve disease; Aortic valve stenosis; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; COMORBIDITY; DEVELOPED COUNTRY; DISEASE SEVERITY; FEASIBILITY STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION;

AORTIC VALVE; BALLOON DILATATION; BIOPROSTHESIS; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC IMAGING; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN;

EID: 77952529844     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.10.14     Document Type: Review

References (66)

1. Iung B, Baron G, Butchart EG et al.: A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart. J. 24 (13), 1231-1243 (2003). A complete and clear overview of valve disease in Europe.
2. Lichtenstein V, Cheung A, Ye J et al.: Transapical transcatheter aortic valve implantation in humans. Circulation 114 (6), 591-596 (2006).
3. Schwarz F, Baumann P, Manthey et al.: The effect of aortic valve replacement on survival. Circulation 66 (5), 1105-1110 (1982).
4. Bonow RO, Carabello BA, Chatterjee K et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 (5), E84-E231 (2006).
5. Otto CM, Mickel MC, Kennedy JW et al.: Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation 89 (2), 642-650 (1994).
6. Carabello B: Aortic stenosis. Lancet 373 (9667), 956-966 (2009).
7. Ross J Jr, Braunwald E: Aortic stenosis. Circulation 38 (1 Suppl.), 61-67 (1968).
8. Kapadia SR, Goel SS, Svensson L et al.: Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J. Thorac. Cardiovasc. Surg. 137 (6), 1430-1437 (2009).
9. Cohn LH, Adams DH, Couper GS et al.: Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann. Surg. 226 (4), 421-426 (1997).
10. Huber CH, von Segesser LK: Direct access valve replacement (DAVR) - are we entering a new era in cardiac surgery? Eur. J. Cardiothorac. Surg. 29 (3), 380-385 (2006).
11. Lieberman EB, Bashore TM, Hermiller JB et al.: Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J. Am. Coll. Cardiol. 26 (6), 1522-1528 (1995).
12. Andersen HR, Knudsen LL, Hasenkam JM et al.: Transluminal implantation of artifcial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J. 13 (3), 704-708 (1992).
13. Bonhoeffer P, Boudjemline Y, Saliba Z et al.: Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356 (9239), 1403-1405 (2000).
14. Cribier A, Eltchaninoff H, Bash A et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (24), 3006-3008 (2002). This work began a new era in valve disease therapies.
15. Culliford AT, Galloway AC, Colvin SB et al.: Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am. J. Cardiol. 67 (15), 1256-1260 (1991).
16. Birkmeyer JD, Siewers AE, Finlayson EV et al.: Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 346 (15), 1128-1137 (2002).
17. Kvidal P, Bergstrodie;m R, Malm T et al.: Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur. Heart J. 21 (13), 1099-1111 (2000).
18. Roques F, Michel P, Goldstone AR, Nashef SA: The logistic EuroSCORE. Eur. Heart J. 24 (9), 881-882 (2003).
19. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J: The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann. Thorac. Surg. 63 (3), 903-908 (1997).
20. Grossi EA, Schwartz CF, Yu PJ et al.: High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann. Thorac. Surg. 8 (1), 102-106 (2008).
21. Chan V, Jamieson WR, Germann E et al.: Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J. Thorac. Cardiovasc. Surg. 131 (6), 1267-1273 (2006).
22. El Oakley R, Kleine P, Bach DS: Choice of prosthetic heart valve in today's practice. Circulation 117 (2), 253-256 (2008).
23. Walther T, Falk V, Dewey T et al.: Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J. Am. Coll. Cardiol. 50 (1), 56-60 (2007). (Pubitemid 46970876)
24. Laborde JC: Access and closure issues the subclavian/trans-axillary approach. Presented at: Trancatheter Valve Therapies. Seattle, WA, USA, 25-26 June, 2009.
25. Eltchaninoff H, Tron C, Bauer F et al.: Aortic bioprosthesis implanted percutaneously: three year follow up. Arch. Mal. Coeur. Vaiss. 100 (11), 901-908 (2007).
26. Lefevre T: The SOURCE Registry Presented at: Transcatheter Cardiovascular Therapeutics. Washington, DC, USA, 13 October, 2008.
27. Webb JG, Chandavimol M, Thompson CR et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (6), 842-850 (2006).
28. Al-Attar: Unexpected complications of transapical aortic valve implantation. Ann. Thorac. Surg. 88 (1), 90-94 (2009).
29. Lichtenstein SV, Cheung A, Ye J et al.: Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114 (6), 591-596 (2006).
30. Svensson LG, Dewey T, Kapadia S et al.: United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac. Surg. 86 (1), 46-55 (2008).
31. Walther T, Simon P, Dewey T et al.: Transapical minimally invasive aortic valve implantation. Multicenter experience. Circulation 116 (Suppl. I), I240-I245 (2007). (Pubitemid 47480797)
32. Walther T: Transapical aortic valve implantation: Traverce Feasibility Study. Presented at: Transcatheter Cardiovascular Therapeutics. Washington, DC, USA 13 October, 2008.
33. Walther T, Falk V, Dewey T et al.: Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J. Am. Coll. Cardiol. 50 (1), 56-60 (2007). (Pubitemid 46970876)
34. Bleiziffer Ruge H, Mazzitelli D et al.: Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur. J. Cardiothorac. Surg. 35 (4), 615-621 (2009).
35. Walther T, Falk V, Kempfert J et al.: Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 35 (2), 376-377 (2008).
36. Ye J, Cheung A, Lichtenstein SV et al.: Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. J. Thorac. Cardiovasc. Surg. 137 (1), 167-173 (2009).
37. Grube E, Laborde JC, Gerckens U et al.: Percutaneous implantation of the CoreValve self expanding valve prosthesis in high risk patients with aortic valve disease. Circulation 114 (15), 1616-1624 (2006).
38. ™ prosthesis. J. Am. Coll. Cardiol. 50 (1), 69-76 (2007).
39. ™ System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Eurointervention 4 (2), 242-249 (2008).
40. Laborde JC: Transcatheter aortic valve implantation with the CoreValve ReValving Device. Presented at: Transcatheter Cardiovascular Therapeutics. Washington, DC, USA, 12 October 2008.
41. ™ bioprosthesis. Am. Heart J. 157 (5), 860-866 (2009).
42. Ussia GP, Mulè M, Tamburino C: The valve-in-valve technique: transcatheter treatment of aortic bioprothesis malposition. Catheter Cardiovasc. Inter. 73 (5), 713-716 (2009).
43. Paniagua D, Condado JA, Besso J et al.: First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex. Heart Inst. J. 32 (3), 393-398 (2005).
44. Schofer J, Treede H et al.: Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis. A first-in-man feasibility and safety study. Circ. Cardiovasc. Intervent. 4 (1), 126-133 (2008).
45. Low RI, Bolling SF, Yeo KK, Ebner A: Direct flow medical percutaneous aortic valve: proof of concept. EuroIntervention 4 (2), 256-261 (2008).
46. Buellesfeld L, Gerckens U, Grube E: Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter. Cardiovasc. Interv. 71, 579-584 (2008). Demonstrated redeliverability of percutaneous prostheses.
47. Shrestha M, Khaladj N, Bara C, Hoeffler K, Hagl C, Haverich A: Staged Approach towards Interventional Aortic Valve Implantation with a Sutureless Valve: initial human implants. Thorac. Cardiovasc. Surg. 56 (7), 398-400 (2008).
48. Lauten A, Ferrari M, Petri A et al.: Experimental evaluation of the JenaClip transcatheter aortic valve. Catheter. Cardiovasc. Interv. DOI: 2009 (Epub ahead of print). Completely new percutaneous prosthesis.
49. Zegdi R, Khabbaz Z, Borenstein N, Fabiani JN: A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. J. Am. Coll. Cardiol. 48 (7), 1365-1368 (2006).
50. Steinhoff G, Stock U, Karim N et al.: Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102 (19 Suppl 3), III 50-55 (2000).
51. Stock UA, Degenkolbe I, Attmann T, Schenke-Layland K, Freitag S, Lutter G: Prevention of devicerelated tissue damage during percutaneous deployment of tissueengineered heart valves. J. Thorac. Cardiovasc. Surg. 13 (11), 323-330 (2006).
52. Falk V, Schwammenthal EE, Kempfert J et al.: New Anatomically Oriented Transapical Aortic Valve Implantation. Ann. Thor. Surg. 87, 925-926 (2009).
53. Vahanian A, Alfieri O, Al-Attar N et al.: Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart. J. 29 (11), 1463-1470 (2008). The first European consenus document regarding percutaneous valvular prostheses.
54. Al-Attar N, Himbert D, Descoutures F et al.: Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann. Thorac. Surg 87 (6), 1757-1762 (2009).
55. Roques F, Nashef SA, Michel P: EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J. Heart. Valve. Dis. 10 (5), 572-577 (2001).
56. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM: Generic, simple risk stratification model for heart valve surgery. Circulation 12 (2), 224-231 (2005).
57. Tops LF, Wood DA, Delgado V et al.: Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 1 (3), 321-330 (2008).
58. Moss RR, Ivens E, Pasupati S et al.: Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging 1 (1), 15-24 (2008).
59. Grunkemeier GL, Jin R, Starr A.: Prosthetic heart valves: objective performance criteria versus randomized clinical trial. Ann. Thorac. Surg. 82 (3), 776-780 (2006).
60. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG: Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 101 (7), 765-771 (2000).
61. Chiam P T, Ruiz CE: Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. JACC Cardiovasc. Interv. 1 (4), 341-350 (2008).
62. Salizzoni S, Bajona P, Zehr KJ et al.: Transapical off-pump removal of the native aortic valve: a proof-of-concept animal study. J. Thorac. Cardiovasc. Surg. 138, 468-473 (2009).
63. Guyatt GH, Ferrans CE, Halyard MY et al.: Exploration of the value of healthrelated quality-of-life information from clinical research and into clinical practice. Mayo Clin. Proc. 82 (10), 1229-1239 (2007).
64. Webb JG, Altwegg L, Boone RH et al.: Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119 (23), 3009-3016 (2009).
65. Webb JG, Pasupati S, Humphries K et al.: Percutaneous transarterial aortic valve replacement in selcted high-risk patients with aortic stenosis. Circulation 116 (7), 755-763 (2007).
66. Zierer A, Wimmer-Greinecker G, Martens S et al.: The transapical approach for aortic valve implantation. J. Thorac. Cardiovasc. Surg. 136 (4), 948-953 (2008).